user

Treatment with adalimumab (Humira®) is safe and effective in psoriatic arthritis (PsA) patients in real-life clinical practice:: Preliminary results of the stereo trial

被引：0
|
作者：
Vandenbosch, F. [1 ]
McHugh, N. J. [2 ]
Reece, R. [3 ]
Cooper, R. [4 ]
Manger, B. [5 ]
Goupille, P. [6 ]
FitzGerald, O. [7 ]
Kron, M. [8 ]
Frank, M. [8 ]
Kupper, H. [8 ]
Roedevand, E. [9 ]
Holck, P. [10 ]
VanVollenhoven, R. [11 ]
Leirisalo-Repo, M. [12 ]
机构：
[1] Univ Hosp, Ghent, Belgium
[2] Royal Natl Hosp Rheumat Dis, Bath BA1 1RL, Avon, England
[3] Huddersfield Royal Infirm, Huddersfield, W Yorkshire, England
[4] Hope Hosp, Salford M6 8HD, Lancs, England
[5] Univ Erlangen Nurnberg, Erlangen, Germany
[6] CHU Tours, Hop Trousseau, Tours, France
[7] St Vincents Univ Hosp, Dublin, Ireland
[8] Abbott GmbH & Co KG, Ludwigshafen, Germany
[9] St Olavs Hosp, Trondheim, Norway
[10] Silkeborg Centralsygehus, Silkeborg, Denmark
[11] Karolinska Univ Hosp, Stockholm, Sweden
[12] Univ Hosp, Helsinki, Finland
来源：
RHEUMATOLOGY | 2007年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：I52 / I53
页数：2
相关论文
共 50 条
  • [11] Adalimumab (HUMIRA®) is effective in combination with various disease-modifying anti-rheumatic drugs for joint and skin symptoms in patients with psoriatic arthritis (PsA):: Results of the STEREO trial
    Van den Bosch, Filip
    McHugh, Neil
    Roedevand, Erik
    Holck, Palle
    Kron, Martina
    Kary, Sonja
    Kupper, Hartmut
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S576 - S576
  • [12] PATIENTS WITH PSORIATIC ARTHRITIS (PSA) TREATED WITH ADALIMUMAB ACHIEVED CLINICAL REMISSION AND GOOD CLINICAL RESPONSES IN THE STEREO TRIAL
    Reece, Richard
    Van den Bosch, Filip
    Manger, Bernhard
    Goupille, Philippe
    Kron, Martina
    Kary, Sonja
    Kupper, Hartmut
    RHEUMATOLOGY, 2009, 48 : I55 - I56
  • [13] Adalimumab (HUMIRA®) is effective and well-tolerated in combination with traditional DMARDs in treating rheumatoid arthritis in real-life clinical practice.
    Ivorra, J. A. Román
    Valesini, G.
    Bijlsma, J. W. J.
    Unnebrink, K.
    Oezer, U.
    Kupper, H.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S404 - S404
  • [14] Adalimumab (HUMIRA®) is effective in treating patients with rheumatoid arthritis who previously failed etanercept and/or infliximab in real-life clinical settings.
    Bombardieri, S
    Tzioufas, AG
    McKenna, F
    Özer, Ü
    Kupper, H
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S144 - S144
  • [15] EFFECTIVE TREATMENT FOR JOINT AND SKIN SYMPTOMS WITH ADALIMUMAB IN COMBINATION WITH VARIOUS DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDs) IN PATIENTS WITH PSORIATIC ARTHRITIS (PsA): RESULTS OF THE STEREO TRIAL
    McHugh, Neil
    van den Bosch, Filip
    Roedevand, Erik
    Holck, Palle
    Kron, Martina
    Kary, Sonja
    Kupper, Hartmut
    RHEUMATOLOGY, 2009, 48 : I6 - I7
  • [16] Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective Study
    D'Angelo, Salvatore
    Cantini, Fabrizio
    Ramonda, Roberta
    Cantarini, Luca
    Carletto, Antonio
    Chimenti, Maria Sole
    Delle Sedie, Andrea
    Foti, Rosario
    Gerli, Roberto
    Lomater, Claudia
    Lubrano, Ennio
    Marchesoni, Antonio
    Zabotti, Alen
    Salvarani, Carlo
    Scrivo, Rossana
    Scarpa, Raffaele
    Tramontano, Giuseppina
    Nannini, Carlotta
    Lorenzin, Mariagrazia
    Fabbroni, Marta
    Martinis, Federica
    Perricone, Roberto
    Carli, Linda
    Visalli, Elisa
    Rovera, Guido
    Perrotta, Fabio Massimo
    Quartuccio, Luca
    Altobelli, Alessio
    Costa, Luisa
    Niccoli, Laura
    Ortolan, Augusta
    Caso, Francesco
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [17] COMPARATIVE EFFECTIVENESS OF TOFACITINIB (TF) AND ADALIMUMAB (ADA) IN PSORIATIC ARTHRITIS (PSA) PATIENTS IN REAL CLINICAL PRACTICE.
    Loginova, E.
    Korotaeva, T.
    Gubar, E.
    Korsakova, Y.
    Glukhova, S.
    Vasilenko, E.
    Vasilenko, A.
    Kuznetsova, N.
    Patrikeeva, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1164 - 1164
  • [18] Adalimumab (Humira®) is effective and safe in the treatment of rheumatoid arthritis across all participating countries in the react trial
    Navarro-Sarabia, F.
    Gromnica-Ihle, E.
    Settas, L.
    Bijisma, J. W. J.
    McIlraith, M.
    Kupper, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 334 - 334
  • [19] Adalimumab is effective and well-tolerated in treating Ankylosing Spondylitis (AS) in real-life clinical practice: subanalysis of results for Swiss patients in the RHAPSODY trial
    Villiger, P.
    Blumhardt, S.
    Michel, B.
    Frey, P.
    Theiler, R.
    SWISS MEDICAL WEEKLY, 2008, 138 : 7S - 7S
  • [20] Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data
    Dattola, Annunziata
    Cannizzaro, Maria Vittoria
    Mazzeo, Mauro
    Bianchi, Luca
    DERMATOLOGY AND THERAPY, 2017, 7 (04) : 485 - 492
12345